While public health officials and hospital representatives are portraying Hantavirus pulmonary syndrome as being unassailable, waiting for a vaccine to arrive, the story on favipiravir is being suppressed.
Scientific Review: Favipiravir (T-705) in Hantavirus Pulmonary Syndrome (HPS)
Mechanism of Action
…
The post Beyond the Breach: Taming the Hantavirus Threat with Favipiravir appeared first on Global Research.